Patents Assigned to Henry Ford Health System
  • Publication number: 20160050992
    Abstract: An adjustable front-opening hospital gown includes first and second front panels having respective mating fasteners, a rear panel, and an orientation feature such as a V-neck or other type of collar. The first front panel overlaps the second front panel in front of a torso of a patient. The rear panel is connected to the front panels, and defines an elongated slot that is overlapped or otherwise remains closed when access to a back of the patient is not required. The orientation feature identifies a designated front of the hospital gown. The gown may include intravenous access flaps, each positioned between the rear panel and a respective front panel. The rear panel may include first and second rear panels, one of which includes an edge overlapped by the other of the panel within the elongated slot to close the elongated slot.
    Type: Application
    Filed: October 2, 2015
    Publication date: February 25, 2016
    Applicant: HENRY FORD HEALTH SYSTEM
    Inventors: Michael P. Forbes, Patrick Houin, Frantz Mondesir, Callie Clark
  • Patent number: 9179716
    Abstract: A front-opening hospital gown includes first and second front panels. The first front panel overlaps the second front panel when the gown is worn by a patient. The second front panel has fasteners in multiple columns and rows. The first front panel has mating fasteners, for instance a single column of multiple rows. The number of rows on the front panels may be equal. An additional rear panel(s) defines an elongated slot on the back of the gown for access to the patient's back. The gown may include an anti-microbial coating, colored fabric that indicates the size of the gown, an RFID tag, color-coded intravenous access flaps, and a telemetry pocket. The intravenous access flaps may have color-coded fasteners or backing twill material. The gown may include a collar indicating the front of the gown. The collar may have a contrasting color relative to a color of the panels.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: November 10, 2015
    Assignee: Henry Ford Health System
    Inventors: Michael P. Forbes, Patrick Houin, Frantz Mondesir, Callie Clark
  • Patent number: 9149509
    Abstract: Thymosin ?4 can be used to treat neuronal and brain injuries that are accompanied by neuronal cell death or injury, including injuries caused by stroke or trauma and injuries caused by neurological and neurodegenerative disease. In particular, stroke and multiple sclerosis are examples of conditions which may be ameliorated by treatment with thymosin ?4. Thymosin ?4 has been found to restore neurological tissue through several effects on several neurological parameters which are improved by administration of thymosin ?4 to a subject in need of neurological tissue restoration. For example, thymosin ?4 improves axonal myelination, migration of neural progenitor cells, neural progenitor cell proliferation, differentiation of neural progenitor cells into mature neurons, differentiation of neural progenitor cells into mature glia, nerve regeneration, and brain remodeling at locations of brain injury.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: October 6, 2015
    Assignee: HENRY FORD HEALTH SYSTEM
    Inventors: Michael Chopp, Zhenggang Zhang, Daniel C. Morris
  • Publication number: 20150224175
    Abstract: Without limitation, some embodiments comprise a method of treatment for promoting recovery of peripheral neuropathy in a subject, including administering to a subject in need of such treatment a therapeutically effective amount of a composition comprised of thymosin beta 4, amino acid sequences LKKTET or LKKTNT, and/or any conservative variants thereof, or an agent that stimulates production of any of those materials, or a conservative variant thereof.
    Type: Application
    Filed: December 21, 2012
    Publication date: August 13, 2015
    Applicant: HENRY FORD HEALTH SYSTEM
    Inventors: Michael Chopp, Zhenggang Zhang, Daniel C. Morris, Lei Wang
  • Patent number: 9074019
    Abstract: Methods, systems and compositions comprising novel peptidomimetics are disclosed that can be used to inhibit calpain and, more specifically, to treat tissue damage caused by pathologic activation of calpains.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: July 7, 2015
    Assignee: HENRY FORD HEALTH SYSTEMS
    Inventors: John Anagli, Donald Seyfried
  • Publication number: 20150157666
    Abstract: Some embodiments comprise methods, systems, and compositions to produce and/or administer modified exosomes or other vesicles containing one or more selected microRNAs, including but not limited to, miR-146b. Some embodiments also comprise the therapeutic administration and use of such modified exosomes and/or producer cells to treat mammalian injuries and diseases, including in human beings.
    Type: Application
    Filed: December 13, 2012
    Publication date: June 11, 2015
    Applicant: Henry Ford Health System
    Inventors: Mark E. Katakowski, Benjamin A.L. Buller, Michael Chopp
  • Patent number: 8990135
    Abstract: A method for assessing whether a patient is at risk of developing a clinical condition includes receiving training data representing a set of patient-related variables for each of a plurality of patients; generating model data based on the received training data; receiving target data representing the set of patient-related variables for a target patient; determining a risk level for the target patient of developing the clinical condition; and indicating the risk level of the target patient, where the set of patient-related variables consists of a first set of variables when the clinical condition is a mortality condition and a second set of variables when the clinical condition is a morbidity condition.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: March 24, 2015
    Assignees: The Regents of the University of Michigan, Henry Ford Health System
    Inventors: Zeeshan H. Syed, Ilan S. Rubinfeld
  • Patent number: 8974394
    Abstract: A device and method for determining intravascular pressure and irregular needle placement in a hemodialysis procedure include analyzing means for automatically deriving venous access pressure (VAP) at a location of venous needle insertion into the patient and determining a ratio of VAP to mean arterial pressure, where the analyzing means determines multiple VAP values over multiple time periods and determines multiple ratios, one for each VAP value. Detecting means compare each ratio to a predetermined standard ratio derived from a moving average of prior VAP ratios, where the detecting means detects irregular needle placement when elevation of the ratio above the standard ratio is indicated.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: March 10, 2015
    Assignee: Henry Ford Health System
    Inventors: Stanley Frinak, Gerard Zasuwa, Jerry Yee, Anatole Besarab, John B. Kennedy, Douglas S. Curry, Helen Kimball Hirschman
  • Patent number: 8945036
    Abstract: The present invention includes a comprehensive replacement fluid system and method for the delivery of regional citrate anticoagulation (RCA) to extracorporeal blood circuits, wherein the system may include an online clearance monitor (OCM) and a circuit effluent online sensor system (OSS) for the continuous determination of patient plasma content of ultrafilterable solutes.
    Type: Grant
    Filed: February 14, 2012
    Date of Patent: February 3, 2015
    Assignee: Henry Ford Health System
    Inventors: Balazs Szamosfalvi, Stanley Frinak, Jerry Yee
  • Patent number: 8940293
    Abstract: The present invention relates to a treatment of an autoimmune demyelinating disease/disorder. Also included in the present invention is the use of bone marrow stromal cells for the treatment of multiple sclerosis (MS).
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: January 27, 2015
    Assignee: Henry Ford Health System
    Inventors: Yi Li, Michael Chopp
  • Publication number: 20140330249
    Abstract: An injector for delivering an injectate into the myocardium of the heart may be implemented as a catheter or a handheld unit. The injector includes a body, a stabilizer secured to a distal end of the body, and a needle that may be controllably advanced from the distal end of the body. The stabilizer stabilizes the distal end of the body relative to the myocardium while the heart beats. An enlarged region disposed along the needle prevents the needle from being advanced into the myocardium beyond a desired penetration depth. To make an injection, the physician brings the distal end of the body in proximity to the myocardium, actuates the stabilizer to stabilize the distal end relative to the myocardium, and advances the needle into the myocardium. Advancement of the needle is impeded by the enlarged region, thereby placing the needle tip at the desired penetration depth for the injection.
    Type: Application
    Filed: July 17, 2014
    Publication date: November 6, 2014
    Applicant: HENRY FORD HEALTH SYSTEM
    Inventor: Hani N. Sabbah
  • Publication number: 20140228298
    Abstract: Methods, systems and compositions comprising novel peptidomimetics are disclosed that can be used to inhibit calpain and, more specifically, to treat tissue damage caused by pathologic activation of calpains.
    Type: Application
    Filed: February 4, 2014
    Publication date: August 14, 2014
    Applicant: Henry Ford Health Systems
    Inventors: John Anagli, Donald Seyfried
  • Patent number: 8801665
    Abstract: An injector for delivering an injectate into the myocardium of the heart may be implemented as a catheter or a handheld unit. The injector includes a body, a stabilizer secured to a distal end of the body, and a needle that may be controllably advanced from the distal end of the body. The stabilizer stabilizes the distal end of the body relative to the myocardium while the heart beats. An enlarged region disposed along the needle prevents the needle from being advanced into the myocardium beyond a desired penetration depth. To make an injection, the physician brings the distal end of the body in proximity to the myocardium, actuates the stabilizer to stabilize the distal end relative to the myocardium, and advances the needle into the myocardium. Advancement of the needle is impeded by the enlarged region, thereby placing the needle tip at the desired penetration depth for the injection.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: August 12, 2014
    Assignee: Henry Ford Health System
    Inventor: Hani N. Sabbah
  • Publication number: 20140221897
    Abstract: The present invention includes a comprehensive replacement fluid system and method for the delivery of regional citrate anticoagulation (RCA) to extracorporeal blood circuits, wherein the system may include an online clearance monitor (OCM) and a circuit effluent online sensor system (OSS) for the continuous determination of patient plasma content of ultrafilterable solutes.
    Type: Application
    Filed: September 23, 2013
    Publication date: August 7, 2014
    Applicant: Henry Ford Health System
    Inventors: Balazs Szamosfalvi, Stanley Frinak, Jerry Yee
  • Patent number: 8642558
    Abstract: Methods, systems and compositions comprising novel peptidomimetics are disclosed that can be used to inhibit calpain and, more specifically, to treat tissue damage caused by pathologic activation of calpains.
    Type: Grant
    Filed: September 21, 2009
    Date of Patent: February 4, 2014
    Assignee: Henry Ford Health Systems
    Inventors: John Anagli, Donald Seyfried
  • Publication number: 20140024954
    Abstract: A device and method for determining intravascular pressure and irregular needle placement in a hemodialysis procedure include analyzing means for automatically deriving venous access pressure (VAP) at a location of venous needle insertion into the patient and determining a ratio of VAP to mean arterial pressure, where the analyzing means determines multiple VAP values over multiple time periods and determines multiple ratios, one for each VAP value. Detecting means compare each ratio to a predetermined standard ratio derived from a moving average of prior VAP ratios, where the detecting means detects irregular needle placement when elevation of the ratio above the standard ratio is indicated.
    Type: Application
    Filed: January 7, 2013
    Publication date: January 23, 2014
    Applicant: Henry Ford Health System
    Inventors: Stanley Frinak, Gerard Zasuwa, Jerry Yee, Anatole Besarab, John B. Kennedy, Douglas S. Curry, Helen Kimball Hirschman
  • Patent number: 8419711
    Abstract: Structurally supportive material is implanted or injected into cardiac veins as discrete masses at various sites in the cardiac venous system to reinforce the myocardium for the purpose of preventing, moderating, stopping or reversing negative cardiac remodeling due to various adverse cardiac conditions, both acute and chronic, or for the purpose of treating localize anomalies of the heart, or for both purposes. The sites may be arranged in a pattern about one or more chambers of the heart such that the masses cooperatively reduce stress in the chamber wall and reduce chamber size. Some patterns also cause a beneficial global reshaping of the chamber. These changes occur quickly and are sustainable, and have a rapid and sustainable therapeutic effect on cardiac function.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: April 16, 2013
    Assignee: Henry Ford Health System
    Inventor: Hani N. Sabbah
  • Patent number: 8383626
    Abstract: There is provided a method of promoting neurogenesis by administering a therapeutic amount of a nitric oxide donor compound to a patient in need of neurogenesis promotion. Also provided is a compound for providing neurogenesis having an effective amount of a nitric oxide donor sufficient to promote neurogenesis. A nitric oxide compound for promoting neurogenesis is also provided. Further, a method of augmenting the production of brain cells and facilitating cellular structural and receptor changes by administering an effective amount of a nitric oxide donor compound to a site in need of augmentation is provided. There is provided a method of increasing both neurological and cognitive function by administering an effective amount of a nitric oxide donor compound to a patient.
    Type: Grant
    Filed: February 1, 2010
    Date of Patent: February 26, 2013
    Assignee: Henry Ford Health System
    Inventors: Michael Chopp, Rui Lan Zhang
  • Patent number: D728797
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: May 5, 2015
    Assignee: Henry Ford Health System
    Inventor: Fuxiang Zhang
  • Patent number: D734470
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: July 14, 2015
    Assignee: Henry Ford Health System
    Inventor: Fuxiang Zhang